Literature DB >> 29851942

Tobacco Product Use Among Youths With and Without Lifetime Asthma - Florida, 2016.

Keshia M Reid1, Jamie R Forrest1, Lauren Porter1.   

Abstract

The increasing availability of diverse tobacco products has led to complex tobacco product use patterns among youths (1). Use by youths of products containing nicotine in any form is unsafe (2); among young persons with asthma, use of combustible tobacco products, particularly cigarettes, is associated with worsening symptoms, poor asthma control, and an increased need for medical management (3,4). Studies suggest that youths with asthma adopt health risk behaviors, including tobacco product use, at rates similar to or higher than those of youths without asthma (3-7); however, these studies are often limited to a partial list of tobacco product types among high school students. To assess current use (≥1 days during the past 30 days) of one or more of five tobacco product types (cigarettes, electronic cigarettes [defined as e-cigarettes, e-cigars, vape pipes, vaping pens, e-hookah, and hookah pens], hookah, smokeless tobacco, or cigars) among Florida middle school (grades 6-8) and high school (grades 9-12) students with or without a previous medical diagnosis of asthma, the Florida Department of Health analyzed data from the 2016 Florida Youth Tobacco Survey (FYTS). In 2016, 11.1% of middle school and 27.9% of high school students with asthma, and 7.9% of middle school and 24.2% of high school students without asthma, reported any current tobacco product use. Current use of each tobacco product type was considerably higher among students with asthma than among those without asthma. E-cigarettes were the most commonly used tobacco product type reported by middle and high school students with asthma (7.9% and 19.6%, respectively) and without asthma (5.8% and 17.2%, respectively). Statewide tobacco prevention strategies could help reduce all forms of tobacco product use among youths, particularly among those with asthma.

Entities:  

Mesh:

Year:  2018        PMID: 29851942      PMCID: PMC6038902          DOI: 10.15585/mmwr.mm6721a2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


The increasing availability of diverse tobacco products has led to complex tobacco product use patterns among youths (). Use by youths of products containing nicotine in any form is unsafe (); among young persons with asthma, use of combustible tobacco products, particularly cigarettes, is associated with worsening symptoms, poor asthma control, and an increased need for medical management (,). Studies suggest that youths with asthma adopt health risk behaviors, including tobacco product use, at rates similar to or higher than those of youths without asthma (–); however, these studies are often limited to a partial list of tobacco product types among high school students. To assess current use (≥1 days during the past 30 days) of one or more of five tobacco product types (cigarettes, electronic cigarettes [defined as e-cigarettes, e-cigars, vape pipes, vaping pens, e-hookah, and hookah pens], hookah, smokeless tobacco, or cigars) among Florida middle school (grades 6–8) and high school (grades 9–12) students with or without a previous medical diagnosis of asthma, the Florida Department of Health analyzed data from the 2016 Florida Youth Tobacco Survey (FYTS). In 2016, 11.1% of middle school and 27.9% of high school students with asthma, and 7.9% of middle school and 24.2% of high school students without asthma, reported any current tobacco product use. Current use of each tobacco product type was considerably higher among students with asthma than among those without asthma. E-cigarettes were the most commonly used tobacco product type reported by middle and high school students with asthma (7.9% and 19.6%, respectively) and without asthma (5.8% and 17.2%, respectively). Statewide tobacco prevention strategies could help reduce all forms of tobacco product use among youths, particularly among those with asthma. FYTS is a cross-sectional, school-based, pencil-and-paper questionnaire administered to Florida public middle school and high school students.* The consent process for the FYTS is dependent upon the school district administering the survey. Several districts use an active permission form; however, most districts obtain parental consent through passive permission forms that instruct parents to sign the form only if they wish to opt their child out of participation. Student participation is voluntary. Information is collected on indicators of tobacco product use, perceptions of harm, and exposure to secondhand smoke to monitor and guide tobacco prevention and control policies and strategies in Florida. A two-stage cluster probability sampling procedure was used to generate a statewide representative sample of Florida students attending public schools in grades 6–12. Data were self-reported, and no identifying information was collected from participating students. In 2016, a total of 36,082 middle and 33,558 high school students participated in the surveys; combined student and school response rates were 78.0% and 71.0%, respectively (). Lifetime asthma status was assessed with the question “Has a doctor or nurse ever told you that you have asthma?” Response options were “yes,” “no,” and “not sure.” Students who responded “yes” were categorized as having asthma; all other responses were categorized as not having asthma. Students who did not answer the question (9.8%) were excluded from analyses. Current use of tobacco products, defined as use on ≥1 days during the past 30 days, was measured for cigarettes, e-cigarettes, hookah (water pipes), smokeless tobacco products (chewing tobacco, snuff, or dip), and cigars (cigars, cigarillos, or little cigars). “Any tobacco product use” was defined as current use of ≥1 tobacco products, and “multiple tobacco product use” was defined as current use of ≥2 products. Data were statistically weighted to yield representative estimates of Florida middle and high school students attending public schools. Prevalence estimates and corresponding population counts were calculated for current tobacco product use overall and by school level (middle or high) among students with or without asthma. Rao-Scott modified chi-square tests were performed to assess statistically significant differences between students with or without asthma; p values of <0.05 were considered statistically significant. In 2016, 19.5% of middle and 20.6% of high school students in Florida reported lifetime asthma (Table 1). Approximately 190,000 middle and high school students in Florida (8.5% and 24.9%, respectively) reported current use of any tobacco product in 2016, with approximately 86,000 (3.1% and 9.0%, respectively) reporting multiple tobacco product use.
TABLE 1

Prevalence of self-reported diagnosed asthma* among Florida middle and high school students, by school level ── Florida Youth Tobacco Survey, 2016

School levelPrevalence of asthma
% (95% CI)Weighted no.
Total 20.1 (19.7–20.6) 261,786
Middle school19.5 (18.9–20.1)157,468
High school20.6 (20.0–21.2)104,318

Abbreviation: CI = confidence interval.

* Asthma was defined as a “yes” response to the question “Has a doctor or nurse ever told you that you have asthma?”

† Weighted to yield representative estimates of Florida middle and high school students attending public schools.

Abbreviation: CI = confidence interval. * Asthma was defined as a “yes” response to the question “Has a doctor or nurse ever told you that you have asthma?” † Weighted to yield representative estimates of Florida middle and high school students attending public schools. Current use of each tobacco product type was higher among middle and high school students with asthma than among those without asthma (p<0.05) (Table 2). Among students with asthma, 11.1% of middle (approximately 10,000) and 27.9% of high school (34,000) students reported current use of any tobacco product. Conversely, 7.9% of middle (30,000) and 24.2% of high school (116,000) students without asthma reported current use of any tobacco product. Among current users with asthma, 4.2% of middle (4,400) and 10.9% of high school (17,000) students reported multiple tobacco product use, compared with 2.8% of middle (12,000) and 8.6% of high school (52,000) students without asthma. During 2016, e-cigarettes were the most commonly used tobacco product type among middle (7.9%) and high school (19.6%) students with asthma, followed by hookah (3.8% and 9.7%), cigars (2.3% and 7.3%), cigarettes (2.2% and 5.7%), and smokeless tobacco (2.1% and 4.3%).
TABLE 2

Percentage of Florida middle and high school students who reported current tobacco product use,* by tobacco product, school level, and asthma status ── Florida Youth Tobacco Survey, 2016

Tobacco productWith asthma†,§Without asthmaTotal
% (95% CI)Weighted 
no. of users% (95% CI)Weighted 
no. of users% (95% CI)Weighted 
no. of users
Middle school students
Cigarettes2.2 (1.8–2.7)2,2731.4 (1.2–1.6)5,845 1.5 (1.4–1.7) 8,118
Electronic cigarettes7.9 (6.8–8.9)7,2025.8 (5.4–6.2)22,554 6.2 (5.8–6.6) 29,756
Hookah3.8 (3.1–4.5)3,8402.4 (2.1–2.6)9,910 2.7 (2.4–2.9) 13,750
Smokeless tobacco2.1 (1.6–2.5)2,1021.2 (1.0–1.3)4,925 1.3 (1.2–1.5) 7,028
Cigars2.3 (1.8–2.8)2,3851.3 (1.1–1.5)5,654 1.5 (1.3–1.7) 8,039
Any tobacco product**11.1 (9.3–12.3)9,9867.9 (7.4–8.4)29,660 8.5 (8.0–9.0) 39,646
≥2 tobacco products††4.2 (3.6–4.9)4,4262.8 (2.5–3.1)12,146 3.1 (2.8–3.4) 16,572
High school students
Cigarettes5.7 (5.0–6.4)8,6634.6 (4.3–5.0)27,520 4.8 (4.5–5.2) 36,183
Electronic cigarettes19.6 (18.1–21.2)22,97917.2 (16.4–18.0)80,412 17.7 (17.0–18.4) 103,391
Hookah9.7 (8.6–10.7)14,8866.8 (6.3–7.2)40,342 7.4 (6.9–7.8) 55,227
Smokeless tobacco4.3 (3.7–4.9)6,5803.3 (3.0–3.6)19,387 3.5 (3.2–3.8) 25,967
Cigars7.3 (6.5–8.2)11,1875.5 (5.1–5.9)32,874 5.9 (5.5–6.3) 44,061
Any tobacco product**27.9 (26.2–29.6)34,35824.2 (23.3–25.1)116,070 24.9 (24.1–25.8) 150,428
≥2 tobacco products††10.9 (9.8–11.9)17,1148.6 (8.1–9.1)52,057 9.0 (8.6–9.5) 69,171

Abbreviation: CI = confidence interval.

* Current cigarette use was defined as having smoked cigarettes on ≥1 days during the past 30 days; current electronic cigarette use was defined as having used an electronic cigarette on ≥1 days during the past 30 days; current hookah use was defined as having smoked tobacco from a hookah or water pipe on ≥1 days during the past 30 days; current smokeless tobacco use was defined as having used chewing tobacco, snuff, or dip on ≥1 days during the past 30 days; current cigar use was defined as having smoked cigars, cigarillos, or little cigars on ≥1 days during the past 30 days.

† Having asthma was defined as a “yes” response to the question “Has a doctor or nurse ever told you that you have asthma?”

§ Use of each tobacco product type significantly differed by asthma status: Rao-Scott chi-square test; p value <0.05.

¶ Weighted to yield representative estimates of Florida middle and high school students attending public schools.

** Any tobacco product use was defined as having used cigarettes, electronic cigarettes, hookah, smokeless tobacco, or cigars on ≥1 days during the past 30 days.

†† ≥2 tobacco product use was defined as having used two or more tobacco products (cigarettes, electronic cigarettes, hookah, smokeless tobacco, or cigars) on ≥1 days during the past 30 days.

Abbreviation: CI = confidence interval. * Current cigarette use was defined as having smoked cigarettes on ≥1 days during the past 30 days; current electronic cigarette use was defined as having used an electronic cigarette on ≥1 days during the past 30 days; current hookah use was defined as having smoked tobacco from a hookah or water pipe on ≥1 days during the past 30 days; current smokeless tobacco use was defined as having used chewing tobacco, snuff, or dip on ≥1 days during the past 30 days; current cigar use was defined as having smoked cigars, cigarillos, or little cigars on ≥1 days during the past 30 days. † Having asthma was defined as a “yes” response to the question “Has a doctor or nurse ever told you that you have asthma?” § Use of each tobacco product type significantly differed by asthma status: Rao-Scott chi-square test; p value <0.05. ¶ Weighted to yield representative estimates of Florida middle and high school students attending public schools. ** Any tobacco product use was defined as having used cigarettes, electronic cigarettes, hookah, smokeless tobacco, or cigars on ≥1 days during the past 30 days. †† ≥2 tobacco product use was defined as having used two or more tobacco products (cigarettes, electronic cigarettes, hookah, smokeless tobacco, or cigars) on ≥1 days during the past 30 days.

Discussion

In 2016, Florida middle and high school students with asthma reported higher current use of each tobacco product type, including use of multiple tobacco products, than did students without asthma. The higher use of each tobacco product type among students with asthma, most notably combustible products (e.g., cigarettes), is concerning because health risks associated with tobacco product use are higher for this population (,). Among middle and high school students with asthma who reported current use of tobacco products, e-cigarettes were the most commonly reported tobacco product type used, followed by hookah, cigars, cigarettes, and smokeless tobacco. Higher current use of all tobacco product types among youths with asthma might be explained by some of the same factors associated with cigarette smoking in this population, including exposure to tobacco product use in the social environment and use as a coping mechanism for psychosocial distress (,). Youths with asthma who are nonadherent to their asthma medication regimen also report being more rebellious and risk-taking, making them more likely to engage in health-compromising behaviors (). Finally, high prevalence of e-cigarette and hookah use might reflect perceptions among youths that these products are more socially acceptable or less harmful than cigarettes, cigars, and smokeless tobacco (,). However, the use of products containing nicotine in any form among youths, including e-cigarettes, is unsafe (). The findings in this report are subject to at least four limitations. First, FYTS data are only collected from middle and high school students who attend public schools and are therefore not representative of all students or youths in Florida. Second, FYTS data are self-reported and therefore subject to recall and response bias. Third, past-30-day use of tobacco products might not reflect regular or daily use. Finally, because of questionnaire wording, it was not possible to ascertain the proportion of e-cigarette users who were vaporizing liquids containing nicotine versus other substances. Statewide tobacco prevention strategies, particularly among youths with asthma, coupled with other proven interventions, are important to reducing all forms of tobacco product use among youths. As the diversity of tobacco products increases, measures to educate youths about the health risks for all tobacco product types are warranted, particularly among those with asthma.

What is already known about this topic?

Among young persons with asthma, use of combustible tobacco products, particularly cigarettes, worsens symptoms and increases need for medical management.

What is added by this report?

Current use of all tobacco product types and multiple tobacco products was significantly higher among students with asthma than among those without asthma. E-cigarettes were the most commonly reported tobacco product type used by middle and high school students with asthma (7.9% and 19.6%, respectively) and without asthma (5.8% and 17.2%, respectively).

What are the implications for public health practice?

Statewide tobacco prevention strategies could help reduce all forms of tobacco product use among youths, particularly among those with asthma.
  8 in total

Review 1.  Smoking rates and the state of smoking interventions for children and adolescents with chronic illness.

Authors:  Vida L Tyc; Leslee Throckmorton-Belzer
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

2.  Youth tobacco product use in the United States.

Authors:  Youn Ok Lee; Christine J Hebert; James M Nonnemaker; Annice E Kim
Journal:  Pediatrics       Date:  2015-02-02       Impact factor: 7.124

3.  E-Cigarette Use Among Florida Youth With and Without Asthma.

Authors:  Kelvin Choi; Debra Bernat
Journal:  Am J Prev Med       Date:  2016-04-13       Impact factor: 5.043

4.  Prevalence of and beliefs about electronic cigarettes and hookah among high school students with asthma.

Authors:  David A Fedele; Tracey E Barnett; David Dekevich; Linda M Gibson-Young; Mary Martinasek; Meredith A Jagger
Journal:  Ann Epidemiol       Date:  2016-10-26       Impact factor: 3.797

5.  US prevalence and trends in tobacco smoke exposure among children and adolescents with asthma.

Authors:  Brian K Kit; Alan E Simon; Debra J Brody; Lara J Akinbami
Journal:  Pediatrics       Date:  2013-02-11       Impact factor: 7.124

6.  Hookah smoking and harm perception among asthmatic adolescents: findings from the Florida youth tobacco survey.

Authors:  Mary P Martinasek; Linda Gibson-Young; Jamie Forrest
Journal:  J Sch Health       Date:  2014-05       Impact factor: 2.118

7.  Cigarette Smoking and Alcohol Use among Adolescents and Young Adults with Asthma.

Authors:  Elizabeth Burgess Dowdell; Michael A Posner; M Katherine Hutchinson
Journal:  Nurs Res Pract       Date:  2011-12-15

8.  Active smoking among asthmatic youth--how concerned we need to be.

Authors:  Aida Semic-Jusufagic; Adnan Custovic
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  8 in total
  9 in total

1.  Smoking Assessment and Current Smoking Status Among Adolescents in Primary Care Settings.

Authors:  Steffani R Bailey; Katie Fankhauser; Miguel Marino; Teresa Schmidt; Sophia Giebultowicz; David Ezekiel-Herrera; John Heintzman
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

2.  Predicting Young Adult Tobacco, Drug and Alcohol Use Among Participants in the CAMP Trial.

Authors:  Robert D Annett; Abu Yusuf Ansari; Chad Blackshear; Bruce G Bender
Journal:  J Clin Psychol Med Settings       Date:  2022-01-10

3.  E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States.

Authors:  Benjamin W Chaffee; Jessica Barrington-Trimis; Fei Liu; Ran Wu; Rob McConnell; Suchitra Krishnan-Sarin; Adam M Leventhal; Grace Kong
Journal:  Prev Med       Date:  2021-08-19       Impact factor: 4.637

Review 4.  A Review of Toxicity Mechanism Studies of Electronic Cigarettes on Respiratory System.

Authors:  Lilan Wang; Yao Wang; Jianwen Chen; Peiqing Liu; Min Li
Journal:  Int J Mol Sci       Date:  2022-05-01       Impact factor: 6.208

5.  Electronic vapor products, marijuana use, smoking, and asthma in US adolescents.

Authors:  Yueh-Ying Han; Franziska Rosser; Erick Forno; Juan C Celedón
Journal:  J Allergy Clin Immunol       Date:  2019-12-09       Impact factor: 10.793

Review 6.  What are the respiratory effects of e-cigarettes?

Authors:  Jeffrey E Gotts; Sven-Eric Jordt; Rob McConnell; Robert Tarran
Journal:  BMJ       Date:  2019-09-30

Review 7.  Cigarette Smoke Exposure, Pediatric Lung Disease, and COVID-19.

Authors:  Marta Schiliro; Elizabeth R Vogel; Lucia Paolini; Christina M Pabelick
Journal:  Front Physiol       Date:  2021-04-27       Impact factor: 4.566

8.  The Co-occurrence of Specialty Vape Shops, Social Disadvantage, and Poor Air Quality in the United States: An Assessment of Cumulative Risks to Youth.

Authors:  P Dilip Venugopal; Aura Lee Morse; Rudaina Alrefai-Kirkpatrick; Cindy Tworek; Hoshing W Chang
Journal:  Health Equity       Date:  2022-02-25

9.  The Association of Asthma, Sexual Identity, and Inhaled Substance Use among U.S. Adolescents.

Authors:  Cindy B Veldhuis; Maureen George; Bethany G Everett; Jianfang Liu; Tonda L Hughes; Jean-Marie Bruzzese
Journal:  Ann Am Thorac Soc       Date:  2021-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.